Eam Global Investors LLC Harrow Health, Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$10.28 - $14.78 $479,860 - $689,915
46,679 Added 70.28%
113,099 $1.67 Million
Q3 2022

Nov 14, 2022
BUY
$6.57 - $24.88 $436,379 - $1.65 Million
66,420 New
66,420 $802,000
Q2 2019

Aug 14, 2019
SELL
$4.2 - $8.7 $144,421 - $299,158
-34,386 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$4.75 - $7.1 $163,333 - $244,140
34,386 New
34,386 $171,000

Others Institutions Holding HROW

# of Institutions
176
Shares Held
21.4M
Call Options Held
845K
Put Options Held
717K
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $1.06B
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email